Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Taro Pharmaceutical Industries Ltd. TARO NYSE

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • IL • USD

SharesGrow Score
63/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Taro Pharmaceutical Industries Ltd. (TARO) has 12 identified peers for comparison in the Healthcare sector. Peers include AMPH, ANIP, COLL, DCPH, EGRX, EVO and others.

TARO has a market capitalization of $1.62B, compared to an average peer market cap of $1.22B.

People Also View

RDY
RDY
Dr. Reddy's Laboratories Limited
$12.94
-1.45%
 SUPN
SUPN
Supernus Pharmaceuticals, Inc.
$49.94
-0.34%
 PBH
PBH
Prestige Consumer Healthcare Inc.
$57.57
+1.61%
 PAHC
PAHC
Phibro Animal Health Corporation
$55.01
-6.79%
 DCPH
DCPH
Deciphera Pharmaceuticals, Inc.
$25.59
+0.08%
 ANIP
ANIP
ANI Pharmaceuticals, Inc.
$76.48
-2.31%
 EVO
EVO
Evotec SE
$3.21
+2.88%
 COLL
COLL
Collegium Pharmaceutical, Inc.
$34.93
-1.99%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message